Clearstead Trust’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $77K | Buy |
173
+9
| +5% | +$4.01K | 0.01% | 271 |
|
2025
Q1 | $79.5K | Sell |
164
-70
| -30% | -$33.9K | 0.02% | 229 |
|
2024
Q4 | $94.2K | Buy |
234
+97
| +71% | +$39.1K | 0.02% | 210 |
|
2024
Q3 | $63.7K | Hold |
137
| – | – | 0.02% | 222 |
|
2024
Q2 | $64.2K | Hold |
137
| – | – | 0.02% | 219 |
|
2024
Q1 | $57.3K | Buy |
137
+70
| +104% | +$29.3K | 0.02% | 232 |
|
2023
Q4 | $27.3K | Sell |
67
-30
| -31% | -$12.2K | 0.01% | 272 |
|
2023
Q3 | $33.7K | Buy |
97
+30
| +45% | +$10.4K | 0.01% | 247 |
|
2023
Q2 | $21.1K | Hold |
67
| – | – | 0.01% | 268 |
|
2023
Q1 | $21.1K | Hold |
67
| – | – | 0.01% | 262 |
|
2022
Q4 | $19K | Hold |
67
| – | – | 0.01% | 284 |
|
2022
Q3 | $19K | Hold |
67
| – | – | 0.01% | 261 |
|
2022
Q2 | $19K | Hold |
67
| – | – | 0.01% | 137 |
|
2022
Q1 | $17K | Buy |
+67
| New | +$17K | 0.01% | 145 |
|
2021
Q4 | – | Sell |
-10,459
| Closed | -$1.9M | – | 197 |
|
2021
Q3 | $1.9M | Sell |
10,459
-294
| -3% | -$53.3K | 1.2% | 25 |
|
2021
Q2 | $2.34M | Sell |
10,753
-735
| -6% | -$160K | 1.53% | 23 |
|
2021
Q1 | $2.47M | Buy |
11,488
+554
| +5% | +$119K | 1.83% | 20 |
|
2020
Q4 | $2.58M | Buy |
+10,934
| New | +$2.58M | 1.54% | 23 |
|
2017
Q3 | – | Sell |
-375
| Closed | -$48K | – | 235 |
|
2017
Q2 | $48K | Buy |
+375
| New | +$48K | 0.04% | 160 |
|